Trends in the risks and benefits to patients with cancer in phase 1 clinical trials.
Ross
Susan
S
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D012306:Risk; D016896:Treatment Outcome
D000970:Antineoplastic Agents